alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 89, Number 20 (Tuesday, January 30, 2024)]
[Notices]
[Pages 5916-5917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01815]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Cure 
Glomerulonephropathy (CureGN) Review.
    Date: March 19, 2024.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, Division of Extramural Activities, NIDDK, 
National Institutes of Health, Room 7345, 6707 Democracy Boulevard, 
Bethesda, MD 20892-5452, (301) 594-8895, 
<a href="/cdn-cgi/l/email-protection#addfd8dec5c4c3caddedc8d5d9dfcc83c3c4c9c9c683c3c4c583cac2db"><span class="__cf_email__" data-cfemail="9ceee9eff4f5f2fbecdcf9e4e8eefdb2f2f5f8f8f7b2f2f5f4b2fbf3ea">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes,

[[Page 5917]]

Endocrinology and Metabolic Research; 93.848, Digestive Diseases and 
Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology 
Research, National Institutes of Health, HHS)

    Dated: January 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01815 Filed 1-29-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 89, Number 16 (Wednesday, January 24, 2024)]
[Notices]
[Page 4603]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01329]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission


Combined Notice of Filings

    Take notice that the Commission has received the following Natural 
Gas Pipeline Rate and Refund Report filings:

Filings in Existing Proceedings

    Docket Numbers: RP11-1711-000.
    Applicants: Texas Gas Transmission, LLC.
    Description: Refund Report: 2023 Cash Out Filing to be effective N/
A.
    Filed Date: 1/18/24.
    Accession Number: 20240118-5015.
    Comment Date: 5 p.m. ET 1/30/24.

    Any person desiring to protest in any the above proceedings must 
file in accordance with Rule 211 of the Commission's Regulations (18 
CFR 385.211) on or before 5:00 p.m. Eastern time on the specified 
comment date.
    The filings are accessible in the Commission's eLibrary system 
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying 
the docket number.
    eFiling is encouraged. More detailed information relating to filing 
requirements, interventions, protests, service, and qualifying 
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call (866) 208-3676 
(toll free). For TTY, call (202) 502-8659.
    The Commission's Office of Public Participation (OPP) supports 
meaningful public engagement and participation in Commission 
proceedings. OPP can help members of the public, including landowners, 
environmental justice communities, Tribal members and others, access 
publicly available information and navigate Commission processes.
    For public inquiries and assistance with making filings such as 
interventions, comments, or requests for rehearing, the public is 
encouraged to contact OPP at (202) 502-6595 or <a href="/cdn-cgi/l/email-protection#0e415e5e4e686b7c6d20696178"><span class="__cf_email__" data-cfemail="29667979694f4c5b4a074e465f">[email protected]</span></a>.

    Dated: January 18, 2024.
Debbie-Anne A. Reese,
Acting Secretary.
[FR Doc. 2024-01329 Filed 1-23-24; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit








Exhibit 10.7


In connection with a review of director compensation in November 2016, the Board of Directors of the Federal Agricultural Mortgage Corporation approved the following level of director compensation in the form of cash retainer and targeted value of equity, effective January 1, 2017:


		
	•
	The base annual cash retainer payable to all directors remained unchanged at $58,400. 




		
	•
	The value of the equity award grant to all directors remained unchanged at $50,000.




		
	•
	The incremental annual cash retainer payable to:




		
	◦
	the Chairman of the Board remained unchanged at $40,000, maintaining his total annual cash retainer at $98,400;




		
	◦
	the Vice Chairman of the Board remained unchanged at $20,000, maintaining his total annual cash retainer at $78,400;




		
	•
	The incremental annual cash retainer payable to Committee chairs is set forth below, provided that no director shall receive the supplemental retainer for being the Chair of one of these four designated Committees if that director is already receiving the supplemental annual retainer applicable to the Chairman of the Board or the Vice Chairman of the Board:




		
	◦
	the Chairman of the Audit Committee remained unchanged at $12,000, maintaining his total annual cash retainer at $70,400;




		
	◦
	the Chairman of the Compensation Committee was increased from $6,500 to $10,000, bringing his total annual cash retainer to $68,400;




		
	◦
	the Chairman of the Corporate Governance Committee was established at $12,000 (the Chairman of the Corporate Governance Committee currently serves as the Chairman of the Board); and 




		
	◦
	the Chairman of the Risk Committee was established at $10,000 (the Chairman of the Risk Committee currently serves as the Vice Chairman of the Board).
Exhibit



Exhibit 10.25







SECOND AMENDMENT OF
 FIRST COMMUNITY FINANCIAL
EMPLOYMENT AGREEMENT
 WITH ROY C. THYGESEN


This SECOND AMENDMENT OF EMPLOYMENT AGREEMENT is made and entered into as of January 1st, 2016 (the "Effective Date"), by and among FIRST COMMUNITY FINANCIAL PARTNERS, INC. ("FCFP"), FIRST COMMUNITY FINANCIAL BANK (the "Bank," and together with FCFP, the "Employer"), and ROY C. THYGESEN ("Executive," and together with the Employer, the "Parties").


RECITALS


A.The Parties have made and entered into that certain Employment Agreement, effective March 12, 2013 (the "Agreement") and as amended as of December 18, 2014.


B.Pursuant to Section 18 of the Agreement, the Agreement may be amended by written agreement signed by the Parties.


C.The Parties desire to eliminate the monthly personal expense allowance and the life insurance reimbursement as specified in the Agreement and incorporate these amounts into the Executive’s Annual Base Salary. 


AGREEMENT


In consideration of the foregoing and the mutual promises and covenants of the Parties set forth in this Amendment, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby expressly agree as follows:


1.Section 3(g) and Section 3(h) of the Agreement are deleted in their entirety (which Sections provided for Life Insurance reimbursement and Personal Expense Allowance, respectively). 


2.The amount of Annual Base Salary in Section 3(a) is modified to $355,000.  All other provisions of this Section 3(a) remain unchanged.


		
	3.
	In all other respects, the Agreement shall remain unchanged and in full force and effect.










[Signature page follows.]






Exhibit 10.25





IN WITNESS WHEREOF, each of FCFP and the Bank has caused this Amendment to be executed in its name and on its behalf, and Executive acknowledges understanding and acceptance of, and agrees to, the terms of this Amendment, all as of the Effective Date.






FIRST COMMUNITY FINANCIAL PARTNERS, INC.
By: /s/George Barr    
Print Name:         George Barr                
Title:         Chairman of the Board of Directors        
FIRST COMMUNITY FINANCIAL BANK
By: /s/George Barr    
Print Name:         George Barr                
Title:         Chairman of the Board of Directors        
ROY C. THYGESEN 
/s/Roy C. Thygesen
Exhibit 32.2
 Certification by Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   /s/           William D. HumesName:
    William D. HumesTitle:
    Executive Vice President and Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S QUARTERLY REORT ON FORM 10-Q FOR THE SIX MONTHS ENDED JUNE 30, 1996
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10-Q.
</LEGEND>
<RESTATED>
<CIK>                        0001011888
<NAME>                       DIATIDE, INC.
<MULTIPLIER>                 1
<CURRENCY>                   U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               JUN-30-1996
<EXCHANGE-RATE>                                      1
<CASH>                                      21,533,945
<SECURITIES>                                   435,000
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            22,259,201
<PP&E>                                       2,068,696
<DEPRECIATION>                               1,079,595
<TOTAL-ASSETS>                              23,409,950
<CURRENT-LIABILITIES>                        3,016,454
<BONDS>                                         17,951
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,210
<OTHER-SE>                                  20,365,335
<TOTAL-LIABILITY-AND-EQUITY>                23,409,950
<SALES>                                              0
<TOTAL-REVENUES>                             1,556,073
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             7,215,847
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              16,176
<INCOME-PRETAX>                            (5,451,193)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (5,451,193)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (5,451,193)
<EPS-PRIMARY>                                   (0.66)
<EPS-DILUTED>                                   (0.66)
<FN>
Schedule restated to reflect impact of Staff Accounting Bulletin No. 98 on
pro forma net loss per share.
</FN>


</TABLE>
1 

### Kelly, Shaheerah

From: Dwight Mallory <Dmallory@resoluteenergy.com>

Sent: Monday, October 12, 2015 9:53 AM

To: Kelly, Shaheerah Subject: RE: Another MCU Question



### Shaheerah,

I think it would be ok to remove that . It is just a column header le ft over from a previous revision.

Sent via the Samsung GALAXY S®4, an AT&T 4G LTE smartphone



### -------- Original message -------- From: "Kelly, Shaheerah" <Kelly.Shaheerah@epa.gov> Date: 10/09/2015 3:43 PM (GMT-07:00) To: Dwight Mallory <Dmallory@resoluteenergy.com> Subject: Another MCU Question

Dwight,

Does the portion highlighted in yellow below need to be in the Isolation and Operating Procedures Document for the
compressors?

Resolute Natural

Resources

McElmo Creek Unit Gas Reinjection Facility Operating Procedure
File Name HOS4COMP

Authorized Page 1 of 8

Date Revised 3/3/15 HOS-4 COMPRESSOR

Equipment. #

************************************ Shaheerah Kelly
Permits Office, Air Division (AIR-3)

U.S. Environmental Protec tion Agency, Region 9
San Francisco, CA 94105

Phone: 415-947-4156

Fax: 415-947-3579

Email: kelly.shaheerah@epa.gov

This e-mail message and any attachments are for the sole use of the intended recipient(s) and may contain confidential, privile ged, and proprietary information of Resolute Energy Corporation. Any unauthorized review, use, disclosure or distribution may be prohibi ted under law. If you are not the intended recipient, please contact the sender by reply E-mail of any erroneous transmission, and destroy the original E-mail, any attach ments, and all copies of the original message. Thank you.
#### Byron NIXON, Plaintiff in Error, v. STATE of Oklahoma, Defendant in Error.

No. A-12222.

Criminal Court of Appeals of Oklahoma.

Dec. 21, 1955.

Rehearing Denied Jan. 11, 1956.

*1044James V. Whitley, Duncan, for plaintiff in error.

Mac Q. Williamson, Atty. Gen., Sam H. Lattimore, Asst. Atty. Gen., for defendant in error.

JONES, Presiding Judge.

This is an appeal from a conviction sustained by the defendant, Byron Nixon in the County Court of Stephens County for the unlawful possession of five pints of whiskey.

Two assignments of error are presented: I. The court erred in overruling a motion to suppress evidence. 2. The court erred in the admission of certain evidence.

The motion to suppress was based upon the contention of the accused that the search warrant did not correctly describe the premises possessed by the áccused and which were searched by the arresting offices. Defendant testified that he rented the premises involved from D. T. Thomas and that the premises were about 100 féét long and 100 feet in width. Counsel for the accused then introduced in evidence the recorded deed to D. T. Thomas conveying a certain tract of land in Section 4, Township 1 South, Range 7 West which was described-by metes and bounds and contained four and- two-ninths acres. The search warrant was then introduced in evidence and the description in the warrant did not fit exactly with the description contained in the deed to Thomas. However, all of the description contained in the search warrant was of a part of the land which was conveyed to Thomas. No further evidence was introduced by the accused. There was no attempt on the part of the accused to show that the description in the search warrant did not cover the premises which were searched. , r

The burden was upon.the movant in the motion to suppress evidence to introduce evidence to show that the search was illegal. Wilson v. State, Okl.Cr., 268 P.2d 585; Littke v. State, 97 Okl.Cr. 78, 258 P.2d 211; Kelso v. State; 97 Okl.Cr. 215, 260 P.2d 864.

Since the accused only had the possession of a tract of land about 100 feet square out of the tract conveyed to Thomas, the description contained in the warrant could very easily have included the premises occupied by the accused. At least the accused failed to testify that the description did not cover his premises.

As to the second assignment of error, theré is considerable merit to a portion of the contention. The case was loosely tried and the court did,' as contended by counsel, overrule some, objections made by counsel to improper questions asked by the county attorney. However, the guilt of the accused was conclusively established, no evidence was offered on behalf of the defendant and the court’s erroneous rulings in overruling objections on two occasions to certain questions asked by the county attorney of- State’s witnesses did not affect the outcome. The penalty of 30- days in the county j ail and a $200 fine was - not excessive and could not be said to have been prompted by passion or prejudice.

Affirmed.

BRETT and POWELL, JJ., concur;
II

104TH CONGRESS

2D SESSION S. 2163

To amend title 18, United States Code, to regulate the manufacture,

importation, and sale of ammunition capable of piercing police body armor.

IN THE SENATE OF THE UNITED STATES

SEPTEMBER 30, 1996

Mr. MOYNIHAN introduced the following bill; which was read twice and

referred to the Committee on the Judiciary

A BILL

To amend title 18, United States Code, to regulate the

manufacture, importation, and sale of ammunition capable of piercing police body armor.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Law Enforcement Offi5 cers Protection Amendment Act of 1996’’.

6 SEC. 2. EXPANSION OF THE DEFINITION OF ARMOR PIERC7 ING AMMUNITION.

8 Section 921(a)(17)(B) of title 18, United States

9 Code, is amended—

10 (1) by striking ‘‘or’’ at the end of clause (i);
2

•S 2163 S

1 (2) by striking the period at the end of clause

2 (ii) and inserting ‘‘; or’’; and

3 (3) by adding at the end the following:

4 ‘‘(iii) a projectile that may be used in

5 a handgun and that the Secretary of the

6 Treasury, in consultation with the Attor7 ney General determines, pursuant to sec8 tion 926(d), to be capable of penetrating

9 body armor.’’.

10 SEC. 3. DETERMINATION OF ARMOR PIERCING CAPABILITY

11 OF PROJECTILES.

12 Section 926 of such title is amended by adding at

13 the end the following:

14 ‘‘(d) Not later than 1 year after the date of enact15 ment of this subsection, the Secretary shall promulgate

16 regulations based on standards to be developed by the Sec17 retary of the Treasury, in consultation with the Attorney

18 General, for the uniform testing of projectiles to determine

19 whether such projectiles are capable of penetrating Na20 tional Institute of Justice Level II–A body armor.

21 SEC. 4. AUTHORIZATION OF APPROPRIATIONS.

22 There are authorized to be appropriated such sums

23 as may be necessary for the Secretary of the Treasury and

24 the Attorney General to—
3

•S 2163 S

1 (1) develop and implement performance stand2 ards for armor piercing ammunition; and

3 (2) promulgate regulations for performance

4 standards for armor piercing ammunition.

Æ
[Federal Register Volume 89, Number 18 (Friday, January 26, 2024)]
[Notices]
[Page 5249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01588]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NST-3 Member SEP.
    Date: February 5, 2024.
    Time: 5:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: New Orleans Marriott, 555 Canal St., New Orleans, LA.
    Contact Person: Lataisia Cherie Jones, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS/NIH/HHS, NSC, 6001 Executive Blvd., Rockville, MD 
20852, 301-496-9223, <a href="/cdn-cgi/l/email-protection#f79b9683969e849e96d99d98999284b7999e9fd9909881"><span class="__cf_email__" data-cfemail="cfa3aebbaea6bca6aee1a5a0a1aabc8fa1a6a7e1a8a0b9">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS.)

    Dated: January 23, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01588 Filed 1-25-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>
                                                                    Exhibit 23.1








Consent of Independent Public Accountants


As independent public accountants, we hereby consent to the inclusion of our
report dated January 21, 2003 in this 10-K/A and to the incorporation by
reference of such report in the Company's previously filed Registration
Statement on Form S-3 (File No. 333-24281) and Registration Statement on Form
S-8 (File No. 333-24269) and Registration Statement on Form S-8 (File No.
333-42016). It should be noted that we have not audited any financial statements
of the Company subsequent to December 31, 2001 or performed any audit procedures
subsequent to the date of our report.


VITALE, CATURANO & COMPANY, P.C.

January 30, 2003
Boston, Massachusetts